XFOR
X4 Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $43.47M | Price | $3.97 |
| Volume | 694.16K | Change | -2.93% |
| P/E Ratio | -1.2 | Open | $4.00 |
| Revenue | $2.6M | Prev Close | $4.09 |
| Net Income | $-37.5M | 52W Range | $1.35 - $26.82 |
| Div Yield | N/A | Target | $8.70 |
| Overall | 52 | Value | 60 |
| Quality | 39 | Technical | 58 |
No chart data available
Stock Overview
Updated DailyX4 Pharmaceuticals Inc. (XFOR) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.97 with a market capitalization of $43.47 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows XFOR with a volume of 694K shares. The stock opened down 2.20% from yesterday's close of $4.09. Current analyst estimates project earnings of $-3.4 per share for this year, with next year targeting $-1.74.
XFOR demonstrates neutral technical outlook based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for XFOR include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 119.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 5, 2025 at 08:22 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XFOR | $3.97 | -2.9% | 694.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |